FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

781096000: Recombinant antihemophilic factor pegylated liposome (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3744873012 Recombinant antihaemophilic factor pegylated liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744874018 Recombinant antihemophilic factor pegylated liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744875017 Recombinant antihemophilic factor pegylated liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Recombinant antihaemophilic factor pegylated liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Recombinant antihemophilic factor agent false Inferred relationship Some
Recombinant antihaemophilic factor pegylated liposome Is a Recombinant protein (substance) true Inferred relationship Some
Recombinant antihaemophilic factor pegylated liposome Is a Antihemophilic factor agent (substance) true Inferred relationship Some
Recombinant antihaemophilic factor pegylated liposome Is a Liposomal agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Recombinant antihaemophilic factor pegylated liposome Inferred relationship Some 1
Product containing recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Recombinant antihaemophilic factor pegylated liposome Inferred relationship Some 1
Product containing recombinant antihemophilic factor pegylated liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Recombinant antihaemophilic factor pegylated liposome Inferred relationship Some 1
Recombinant antihemophilic factor pegylated liposome only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Recombinant antihaemophilic factor pegylated liposome Inferred relationship Some 1

This concept is not in any reference sets

Back to Start